Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $7.0 million.

  • Firefly Neuroscience's Non-Current Assets rose 16368.1% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 16368.1%. This contributed to the annual value of $2.0 million for FY2024, which is 41113.99% up from last year.
  • As of Q3 2025, Firefly Neuroscience's Non-Current Assets stood at $7.0 million, which was up 16368.1% from $7.4 million recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Non-Current Assets high stood at $16.5 million for Q4 2021, and its period low was $386000.0 during Q4 2023.
  • For the 5-year period, Firefly Neuroscience's Non-Current Assets averaged around $5.7 million, with its median value being $2.6 million (2024).
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 488865.16% in 2021, then tumbled by 9254.56% in 2023.
  • Over the past 5 years, Firefly Neuroscience's Non-Current Assets (Quarter) stood at $16.5 million in 2021, then plummeted by 68.6% to $5.2 million in 2022, then plummeted by 92.55% to $386000.0 in 2023, then surged by 411.14% to $2.0 million in 2024, then skyrocketed by 253.62% to $7.0 million in 2025.
  • Its Non-Current Assets stands at $7.0 million for Q3 2025, versus $7.4 million for Q2 2025 and $2.0 million for Q1 2025.